Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 t
about
Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
P2860
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 t
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2015
@uk
name
Patient-reported outcomes in t ...... e adults infected with HIV-1 t
@en
Patient-reported outcomes in the single-tablet regimen
@nl
type
label
Patient-reported outcomes in t ...... e adults infected with HIV-1 t
@en
Patient-reported outcomes in the single-tablet regimen
@nl
prefLabel
Patient-reported outcomes in t ...... e adults infected with HIV-1 t
@en
Patient-reported outcomes in the single-tablet regimen
@nl
P2093
P2860
P1433
P1476
Patient-reported outcomes in t ...... e adults infected with HIV-1 t
@en
P2093
Benoit Trottier
Bernhard Haas
Calvin J. Cohen
Cynthia Brinson
David Thorpe
Don E. Smith
Ed L. Wilkins
Shampa De-Oertel
Stefan Esser
Susan Chuck
P2860
P304
P356
10.1080/09540121.2015.1096890
P577
2015-10-21T00:00:00Z